Roivant Sciences Ltd
F:87S

Watchlist Manager
Roivant Sciences Ltd Logo
Roivant Sciences Ltd
F:87S
Watchlist
Price: 10.85 EUR -8.71% Market Closed
Market Cap: 8B EUR
Have any thoughts about
Roivant Sciences Ltd?
Write Note

Roivant Sciences Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Roivant Sciences Ltd
Cash Equivalents Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Roivant Sciences Ltd
F:87S
Cash Equivalents
$6.5B
CAGR 3-Years
47%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash Equivalents
ÂŁ442.6m
CAGR 3-Years
51%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash Equivalents
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Roivant Sciences Ltd's Cash Equivalents?
Cash Equivalents
6.5B USD

Based on the financial report for Mar 31, 2024, Roivant Sciences Ltd's Cash Equivalents amounts to 6.5B USD.

What is Roivant Sciences Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 3Y
47%

Over the last year, the Cash Equivalents growth was 290%. The average annual Cash Equivalents growth rates for Roivant Sciences Ltd have been 47% over the past three years .

Back to Top